Serum anti-CCNY autoantibody is an independent prognosis indicator for postoperative patients with early-stage nonsmall-cell lung carcinoma.

Ma, Li

Serum anti-CCNY autoantibody is an independent prognosis indicator for postoperative patients with early-stage nonsmall-cell lung carcinoma. [electronic resource] - Disease markers 2013 - 317-25 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1875-8630

10.1155/2013/935943 doi


Adult
Aged
Aged, 80 and over
Autoantibodies--blood
Biomarkers, Tumor--blood
Carcinoma, Non-Small-Cell Lung--blood
Case-Control Studies
Cyclins--genetics
Female
Humans
Lung Neoplasms--blood
Male
Middle Aged
Postoperative Period
Prognosis